Core Insights - The global high-purity phospholipid market is experiencing a clear polarization, with one segment producing low-cost bulk phospholipids through chemical solvent methods, which fail to meet the purity and activity requirements for pharmaceutical and high-end consumer applications [1] - Another segment produces high-purity phospholipids using traditional physical methods, which are costly and primarily used in scientific research and specialized medical fields [1] - Shangao Life Sciences has announced a significant breakthrough with its self-developed APCC-UF technology, establishing a production line for high-activity natural phospholipids that will revolutionize raw material supply in pharmaceuticals, nutrition, and skincare [1] Industry Analysis - The new technology from Shangao achieves "research-grade high-end quality at industrial-grade costs," which is expected to extend phospholipid applications from a hundred billion market to a trillion-level pharmaceutical and high-value health sector [2] - This advancement is anticipated to create new pathways for biomanufacturing in the global supply chain competition [2]
高端磷脂市场迎来变局 开辟生物制造新赛道
Zhong Guo Jing Ji Wang·2025-09-17 09:19